Uppsala, Uppsala Lan, Sweden In 1987 was created Q-Med, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Uppsala. The venture was found in Europe in Sweden.
This organization was formed by Manuel Aguero.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Sweden. Among the various public portfolio startups of the fund, we may underline OxThera Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2007.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Q-Med, startups are often financed by SLS Venture, HealthCap. The meaningful sponsors for the fund in investment in the same round are SLS Venture, Industrifonden, HealthCap. In the next rounds fund is usually obtained by Kurma Partners, Idinvest Partners, Ysios Capital.
Related Funds
| Fund Name | Location |
| Brentwood Venture Capital | California, Menlo Park, United States |
| Catalyst Investors | New York, New York, United States |
| CLARA ONLINE | Chiba, Japan, Minato |
| Debaeque | Barcelona, Catalonia, Spain |
| EDGE Technologies | Amsterdam, Noord-Holland, The Netherlands |
| Georgia Tech Edison Fund | - |
| Macerich | California, Santa Monica, United States |
| MACRO Systems | - |
| Mohammed Bin Rashid Innovation Fund (MBRIF) | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
| Run Liang Tai Fund | - |
| Shandong Yingchuang Touzi | China, Jining, Shandong |
| Sparkle Roll Group | China, Hong Kong, Hong Kong Island |
| Taglich Private Equity | New York, New York, United States |
| Tiger Global Mauritius Fund | - |
| UHA Mikakuto | Japan, Osaka, Osaka Prefecture |
| Yale Law School | Connecticut, New Haven, United States |
| Yida Touzi | China, Fujian, Xiamen |
| Yinling Capital | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 